Optimised, Broad NGS Panel for Inherited Eye Diseases to Diagnose 1000 Patients in Poland

Ewa Matczyńska,Marta Beć-Gajowniczek,Larysa Sivitskaya,Elżbieta Gregorczyk,Przemysław Łyszkiewicz,Robert Szymańczak,Maria Jędrzejowska,Edward Wylęgała,Maciej R. Krawczyński,Sławomir Teper,Anna Boguszewska-Chachulska

DOI: https://doi.org/10.3390/biomedicines12061355

IF: 4.757

2024-06-19

Biomedicines

Abstract:Advances in gene therapy and genome editing give hope that new treatments will soon be available for inherited eye diseases that together affect a significant proportion of the adult population. New solutions are needed to make genetic diagnosis fast and affordable. This is the first study of such a large group of patients with inherited retinal dystrophies (IRD) and inherited optic neuropathies (ION) in the Polish population. It is based on four years of diagnostic analysis using a broad, targeted NGS approach. The results include the most common pathogenic variants, as well as 91 novel causative variants, including frameshifts in the cumbersome RPGR ORF15 region. The high frequency of the ABCA4 complex haplotype p.(Leu541Pro;Ala1038Val) was confirmed. Additionally, a deletion of exons 22–24 in USH2A, probably specific to the Polish population, was uncovered as the most frequent copy number variation. The diagnostic yield of the broad NGS panel reached 64.3% and is comparable to the results reported for genetic studies of IRD and ION performed for other populations with more extensive WES or WGS methods. A combined approach to identify genetic causes of all known diseases manifesting in the posterior eye segment appears to be the optimal choice given the currently available treatment options and advanced clinical trials.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to diagnose patients with hereditary eye diseases in the Polish population, especially hereditary retinal dystrophy (IRD) and hereditary optic neuropathy (ION), through the use of optimized and extensive next - generation sequencing (NGS) panels. The main objectives of the study include:

1. **Improve diagnostic efficiency**: By developing and applying a multigene NGS panel for IRD and ION, increase the diagnosis rate and accuracy of these diseases.
2. **Identify common and novel pathogenic variants**: Identify the most common pathogenic variants and 91 newly discovered pathogenic variants in the Polish population, including frameshift mutations in the RPGR ORF15 region.
3. **Evaluate the advantages and limitations of the diagnostic method**: Evaluate the advantages and limitations of the multigene NGS panel in the diagnosis of patients with IRD and ION, and compare it with other methods such as whole - exome sequencing (WES) and whole - genome sequencing (WGS).
4. **Molecular epidemiology analysis**: Provide molecular epidemiology data on hereditary eye diseases in the Polish population, especially confirm the high frequency of the complex haplotype p.(Leu541Pro;Ala1038Val) in the ABC4 gene, and the exon 22 - 24 deletion specific to the Polish population in the USH2A gene is the most common copy number variation.

Through these objectives, the study aims to provide new solutions for the rapid and cost - effective diagnosis of hereditary eye diseases and provide an important molecular basis for future treatment strategies.